Severe agitation in severe early-onset alzheimer’s disease resolves with ECT

Neuropsychiatric Disease and Treatment

Volumn 10, Issue , 2014, Pages 2147-2151

  Aksay, Suna Su ^a   Hausner, Lucrezia ^a   Frölich, Lutz ^a   Sartorius, Alexander ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cognition; Dementia; Disinhibition; Electroconvulsive therapy; Emotional distress

Indexed keywords

ESKETAMINE; FLUORODEOXYGLUCOSE; LORAZEPAM; MELPERONE; MIRTAZAPINE; PIPAMPERONE; QUETIAPINE; RISPERIDONE; RIVASTIGMINE; SERTRALINE;

ADULT; AGGRESSION; AGITATION; ALZHEIMER DISEASE; ANXIETY; ARTICLE; BEHAVIOR DISORDER; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CRYING; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG TOLERABILITY; ELECTROCONVULSIVE THERAPY; ELECTROCONVULSIVE THERAPY UNIT; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; LANGUAGE DISABILITY; MEDICAL HISTORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RESTLESSNESS; SLEEP DISORDER; TONIC CLONIC SEIZURE; VERBAL COMMUNICATION;

EID: 84910118800     PISSN: None     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S71008     Document Type: Article

References (37)

1. Colenda CC, III. Agitation: A conceptual overview. In: Lawlor BA, editor. Behavioral complications in Alzheimer’s disease. Washington, DC: American Psychiatric Press, Inc; 1995:3-17.
2. Kong EH. Agitation in dementia: concept clarification. J Adv Nurs. 2005;52(5):526-536.
3. Lyketsos CG, Steinberg M, Tschanz JT, Norton MC, Steffens DC, Breitner JC. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry. 2000;157(5):708-714.
4. Ballard CG, Margallo-Lana M, Fossey J, et al. A 1-year follow-up study of behavioral and psychological symptoms in dementia among people in care environments. J Clin Psychiatry. 2001;62(8):631-636.
5. Cohen-Mansfield J. Nonpharmacologic treatment of behavioral disorders in dementia. Curr Treat Options Neurol. 2013;15(6):765-785.
6. Spalletta G, Musicco M, Padovani A, et al. Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease. Am J Geriatr Psychiatry. 2010;18(11): 1026-1035.
7. Scarmeas N, Brandt J, Blacker D, et al. Disruptive behavior as a predictor in Alzheimer disease. Arch Neurol. 2007;64(12):1755-1761.
8. Gitlin LN, Kales HC, Lyketsos CG. Nonpharmacologic management of behavioral symptoms in dementia. JAMA. 2012;308(19):2020-2029.
9. Kong EH, Evans LK, Guevara JP. Nonpharmacological intervention for agitation in dementia: a systematic review and meta-analysis. Aging Ment Health. 2009;13(4):512-520.
10. Schneider LS, Dagerman K, Insel PS. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry. 2006;14(3): 191-210.
11. Ballard C, Hanney ML, Theodoulou M, et al; DART-AD Investigators. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol. 2009;8(2):151-157.
12. Hausner L, Damian M, Sartorius A, Frölich L. Efficacy and cognitive side effects of electroconvulsive therapy (ECT) in depressed elderly inpatients with coexisting mild cognitive impairment or dementia. J Clin Psychiatry. 2011;72(1):91-97.
13. Nelson JP, Rosenberg DR. ECT Treatment of Demented Elderly Patients with Major Depression: A Retrospective Study of Efficacy and Safety. Convuls Ther. 1991;7(3):157-165.
14. Price TR, McAllister TW. Safety and efficacy of ECT in depressed patients with dementia: a review of clinical experience. Convuls Ther. 1989;5(1):61-74.
15. Rao V, Lyketsos CG. The benefits and risks of ECT for patients with primary dementia who also suffer from depression. Int J Geriatr Psychiatry. 2000;15(8):729-735.
16. van der Wurff FB, Stek ML, Hoogendijk WJ, Beekman AT. The efficacy and safety of ECT in depressed older adults: a literature review. Int J Geriatr Psychiatry. 2003;18(10):894-904.
17. Oudman E. Is electroconvulsive therapy (ECT) effective and safe for treatment of depression in dementia? A short review. J ECT. 2012;28(1):34-38.
18. Hausner L, Sartorius A, Kranaster L, Frölich L. Should electroconvulsive therapy be more routinely be used in the treatment of depression in elderly patients with cognitive disturbances? Neuropsychiatry. 2011;1(5):403-407.
19. Wu Q, Prentice G, Campbell JJ. ECT treatment for two cases of dementia-related aggressive behavior. J Neuropsychiatry Clin Neurosci. 2010;22(2):E10-E11.
20. Grant JE, Mohan SN. Treatment of agitation and aggression in four demented patients using ECT. J ECT. 2001;17(3):205-209.
21. Holmberg SK, Tariot PN, Challapalli R. Efficacy of ECT for agitation in dementia: a case report. Am J Geriatr Psychiatry. 1996;4(4):330-334.
22. Bang J, Price D, Prentice G, Campbell J. ECT treatment for two cases of dementia-related pathological yelling. J Neuropsychiatry Clin Neurosci. 2008;20(3):379-380.
23. Sutor B, Rasmussen KG. Electroconvulsive therapy for agitation in Alzheimer disease: a case series. J ECT. 2008;24(3):239-241.
24. Ujkaj M, Davidoff DA, Seiner SJ, Ellison JM, Harper DG, Forester BP. Safety and efficacy of electroconvulsive therapy for the treatment of agitation and aggression in patients with dementia. Am J Geriatr Psychiatry. 2012;20(1):61-72.
25. Acharya D, Harper DG, Achtyes ED, et al. Safety and utility of acute electroconvulsive therapy for agitation and aggression in dementia. Int J Geriatr Psychiatry. Epub 2014 May 16.
26. Burgut FT, Popeo D, Kellner CH. ECT for agitation in dementia: is it appropriate? Med Hypotheses. 2010;75(1):5-6.
27. Burns A, Lawlor B, Craig S. Assessment Scales in Old Age Psychiatry. London: Martin Dunitz Ltd; 1999.
28. Kranaster L, Kammerer-Ciernioch J, Hoyer C, Sartorius A. Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study. Eur Arch Psychiatry Clin Neurosci. 2011;261(8):575-582.
29. Hoyer C, Kranaster L, Janke C, Sartorius A. Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: a retrospective study. Eur Arch Psychiatry Clin Neurosci. 2014;264(3):255-261.
30. Kranaster L, Hoyer C, Janke C, Sartorius A. Bispectral index monitoring and seizure quality optimization in electroconvulsive therapy. Pharmacopsychiatry. 2013;46(4):147-150.
31. Burke A. Pathophysiology of behavioral and psychological disturbances in dementia. In: McNamara P, editor. Dementia. Vol 3. Santa Barbara, CA: Praeger; 2011:135-158.
32. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA. 2001;285(10):1299-1307.
33. Bajbouj M, Lang UE, Niehaus L, Hellen FE, Heuser I, Neu P. Effects of right unilateral electroconvulsive therapy on motor cortical excitability in depressive patients. J Psychiatr Res. 2006;40(4):322-327.
34. Scott AI, Boddy H. The effect of repeated bilateral electroconvulsive therapy on seizure threshold. J ECT. 2000;16(3):244-251.
35. Krystal AD, Coffey CE. Neuropsychiatric considerations in the use of electroconvulsive therapy. J Neuropsychiatry Clin Neurosci. 1997;9(2):283-292.
36. Griesemer DA, Kellner CH, Beale MD, Smith GM. Electroconvulsive therapy for treatment of intractable seizures. Initial findings in two children. Neurology. 1997;49(5):1389-1392.
37. Ray AK. Does electroconvulsive therapy cause epilepsy? J ECT. 2013;29(3):201-205.